RecallTech & trendsToday · Oct 26, 2026Canada

Abbott issues security update for FreeStyle Libre 3 mobile app

Abbott has released a mandatory security update for the FreeStyle Libre 3 app on Android and iOS. A previous patch to address a vulnerability caused a defect that may lead to prolonged communication loss between the app and the sensor. Users must update to version 3.6.10 immediately to resolve this issue.

If you assist patients using this system, ensure they update their app to version 3.6.10 to prevent sensor connection failures.

Ask about this brief

Answers are written by AI from this brief and can be wrong. Check the original source before you act.

2 free questions a day without an account. Members ask as often as they like, free.

Not medical, legal or immigration advice. Questions are kept anonymously to improve our briefs.

Read the original

Official source: Abbott issues security update for FreeStyle Libre 3 mobile app (opens in a new tab) — Health Canada recalls and alerts

Tech & trendsTodayManitobaWinnipeg (WRHA)

Health Sciences Centre performs first stereoelectroencephalography brain surgery in Manitoba

A 14-year-old patient recently underwent the first stereoelectroencephalography brain surgery performed in Manitoba. This procedure at the Health Sciences Centre Children’s Hospital marks a significant step in establishing a comprehensive epilepsy surgery program within the province.

Official source: Shared Health (opens in a new tab)

ResearchTech & trends3 days agoCanada

Personalized mRNA vaccine reduces melanoma recurrence risk in clinical trial

Moderna and Merck's personalized mRNA vaccine intismeran cut the risk of melanoma returning by 42 per cent two years after surgery, in a study of more than 1,100 people with high-risk melanoma. Two years on, 82 per cent of vaccinated patients were recurrence-free, versus 70 per cent on Keytruda alone. The companies are discussing approval with regulators; full results were due at a European oncology meeting in Madrid.

A personalized mRNA vaccine, matched to each patient's tumour, is moving toward approval after a large trial showed a clear gain in living without recurrence.

News source: CBC News (opens in a new tab)

RecallTech & trends5 days agoCanada

Philips warns of potential system failures in Azurion 7 imaging units

Philips has issued a notice regarding Azurion 7 systems that may contain unauthorized solid-state drives. These incorrect components could lead to system failures, including the loss of imaging capabilities, motorized movement issues, or the inability to access and store patient data.

If you use an Azurion 7 system, be aware that unauthorized drives may cause sudden equipment failure or loss of patient data.

Official source: Health Canada recalls and alerts (opens in a new tab)

RecallTech & trends5 days agoCanada

Abbott recalls specific i-STAT cardiac troponin test cartridges over accuracy concerns

Abbott has issued a recall for specific lots of i-STAT hs-TnI cartridges due to manufacturing variability. These cartridges may produce falsely elevated cardiac troponin I results because of reduced interference mitigation. There is no evidence of falsely low test results.

Check your i-STAT hs-TnI cartridge lots against the recall list and stop using any affected units immediately.